| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | ||
|---|---|---|---|---|---|---|
Revenue | ||||||
Medical foods | ||||||
- | - | 245 | - | - | ||
Vision testing diagnostics | ||||||
- | - | 192 | - | - | ||
Total Revenue | ||||||
902 | 942 | - | - | - | ||
Total revenue | ||||||
- | - | 437 | - | - | ||
Cost of goods sold | ||||||
Medical foods | ||||||
- | - | 110 | - | - | ||
Vision testing diagnostics | ||||||
- | - | 64 | - | - | ||
Revenue | ||||||
- | - | - | 141 | 112 | ||
Total Cost of goods sold | ||||||
341 | 398 | 175 | 75 | 50 | ||
Gross profit | ||||||
561 | 543 | 261 | 65 | 62 | ||
Operating expenses | ||||||
Research and development | ||||||
194 | 231 | 259 | 33 | 401 | ||
Sales and marketing | ||||||
1,874 | 1,520 | 599 | 389 | 180 | ||
General and administrative | ||||||
7,425 | 4,934 | 4,683 | 3,339 | 5,610 | ||
Goodwill impairment | ||||||
1,563 | - | - | - | - | ||
Loss on settlement of promissory notes and accounts payable | ||||||
- | - | - | -249 | -258 | ||
Total operating expenses | ||||||
11,058 | 6,687 | 5,543 | 4,011 | 6,451 | ||
Loss from operations | ||||||
-10,496 | -6,143 | -5,281 | -3,945 | -6,388 | ||
Other expenses: | ||||||
Interest expense | ||||||
258 | 2 | 23 | 1,104 | 752 | ||
Finance cost upon issuance of warrants | ||||||
-415 | - | - | - | - | ||
Change in fair value of derivative warrants | ||||||
-292 | - | 0 | - | - | ||
Costs associated with extension of warrant expiration dates | ||||||
- | 1,621 | - | - | - | ||
Total other expenses | ||||||
381 | 1,623 | -23 | - | - | ||
Change in fair value of note | ||||||
- | - | - | -698 | 0 | ||
Cost to induce conversion of notes payable | ||||||
- | - | - | - | 1,699 | ||
Total other expenses | ||||||
- | - | - | 1,802 | 2,452 | ||
Net loss | ||||||
-10,878 | -7,767 | -5,305 | -5,748 | -8,841 | ||
Accretion of deemed dividend | ||||||
- | - | 601 | 760 | 0 | ||
Dividend declared | ||||||
- | - | 308 | 35 | 0 | ||
Net loss attributable to common shareholders | ||||||
- | - | -6,215 | -6,543 | -8,841 | ||
Net loss per common share - basic and diluted | ||||||
-0.30 | -0.38 | -0.45 | -0.30 | -0.54 | ||
Weighted average common shares outstanding - basic and diluted | ||||||
36,468 | 20,188 | 13,934 | 21,800 | 16,391 | ||
Medical Foods [Member] | ||||||
Total Revenue | ||||||
444 | 332 | - | - | - | ||
Total Cost of goods sold | ||||||
155 | 161 | - | - | - | ||
Gross profit | ||||||
289 | 171 | - | - | - | ||
Total operating expenses | ||||||
8,026 | 5,950 | - | - | - | ||
Loss from operations | ||||||
-7,736 | -5,778 | - | - | - | ||
Medical Devices [Member] | ||||||
Total Revenue | ||||||
434 | 609 | - | - | - | ||
Total Cost of goods sold | ||||||
178 | 237 | - | - | - | ||
Gross profit | ||||||
255 | 372 | - | - | - | ||
Goodwill impairment | ||||||
1,563 | - | - | - | - | ||
Total operating expenses | ||||||
1,108 | 664 | - | - | - | ||
Loss from operations | ||||||
-2,416 | -291 | - | - | - | ||
Other [Member] | ||||||
Total Revenue | ||||||
24 | - | - | - | - | ||
Total Cost of goods sold | ||||||
7 | - | - | - | - | ||